Genomma Lab Internacional, S.A.B. de C.V. GNMLF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.84M | 21.55M | 28.14M | 17.83M | 23.31M |
| Total Depreciation and Amortization | 5.21M | 5.20M | 5.16M | 5.18M | 5.12M |
| Total Amortization of Deferred Charges | -- | -- | -- | 1.03M | -- |
| Total Other Non-Cash Items | 16.52M | 20.30M | 13.48M | 17.99M | 2.89M |
| Change in Net Operating Assets | -22.85M | -25.00M | -59.83M | 26.59M | -7.67M |
| Cash from Operations | 28.72M | 22.05M | -13.04M | 68.61M | 23.65M |
| Capital Expenditure | -1.44M | -6.91M | -6.56M | -12.28M | -7.02M |
| Sale of Property, Plant, and Equipment | -1.37M | 2.98M | 56.70K | 422.60K | 6.40K |
| Cash Acquisitions | -653.00K | -3.00M | -235.60K | -7.88M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.79M | 8.98M | 4.18M | -2.45M | -2.28M |
| Cash from Investing | -1.67M | 2.04M | -2.56M | -22.19M | -9.29M |
| Total Debt Issued | 2.40B | 629.52M | 1.19B | 631.91M | 1.15B |
| Total Debt Repaid | -2.20B | -931.11M | -703.66M | -439.99M | -999.49M |
| Issuance of Common Stock | -- | -- | -- | 1.83B | -- |
| Repurchase of Common Stock | -22.07M | -4.69M | -26.57M | -1.83B | -28.76M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.28M | -11.22M | -11.12M | -10.67M | -21.00M |
| Other Financing Activities | -126.58M | -171.56M | -171.23M | -188.48M | -186.45M |
| Cash from Financing | -8.32M | -38.72M | 5.07M | -10.50M | -24.51M |
| Foreign Exchange rate Adjustments | 96.90K | 2.04M | -2.46M | -3.44M | -3.31M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.83M | -12.59M | -12.99M | 32.49M | -13.45M |